2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Рекомендации ESC 2020 года по ведению пациентов с острыми коронарными синдромами без стойкого подъёма сегмента ST
2020-07-10
SCID: 54.1/4csgxum6
Discuss with AI
2020 ESC GuidelinesEuropean Heart Journalacute coronary syndromesnon-ST-segment elevation
Figures from the paper
Abstract (AI)
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
Key Findings
1
No clinical recommendations, outcome data, or specific correction details are provided in the abstract.
2
The document is the 2020 ESC guideline for managing acute coronary syndromes without persistent ST-segment elevation.
3
The provided abstract only reports that a correction to the guideline has been published in the European Heart Journal.
Research Object
Management guidelines for acute coronary syndromes in patients presenting without persistent ST-segment elevation
Research Subject
management of these acute coronary syndromes
Publication Details
Publication Date
2020-07-10
Journal
Publisher
ISSN
Cited by
5038
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai15
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2016
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk2019
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2015
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2016
Fourth universal definition of myocardial infarction (2018)2018
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease2017
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)2019
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes2015
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy2018
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation2018
Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults2010
Cited by12
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2021
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2016
2021 ESC/EACTS Guidelines for the management of valvular heart disease2021
2023 ESC Guidelines for the management of acute coronary syndromes2023
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension2022
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension2023
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2022
The Role of Inflammation in Cardiovascular Disease2022
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus2022
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2021
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension2022